All references are cited in APA 7th edition format. Where available, hyperlinked DOIs are provided for direct article access. References are verified against PubMed records (pubmed.ncbi.nlm.nih.gov). All cited articles are peer-reviewed and indexed in PubMed or equivalent scholarly databases, with the exception of Anderson & Parrish (1983), which predates PubMed indexing and is retrievable via DOI. Evidence quality notes are included where relevant to clinical application.
Foundational Science — Selective Photothermolysis
Anderson, R. R., & Parrish, J. A. (1983). Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science, 220(4596), 524–527. https://doi.org/10.1126/science.6836297
Foundational mechanism paper. Establishes the scientific basis for all BBL/IPL clinical effects. Predates PubMed indexing; accessible via Science journal DOI.
IPL Photorejuvenation — Collagen Remodelling & Skin Quality
Trelles, M. A., Allones, I., & Velez, M. (2003). Non-ablative facial skin photorejuvenation with an intense pulsed light system and adjunctive epidermal care. Lasers in Medical Science, 18(2), 104–111. https://doi.org/10.1007/s10103-003-0257-7
Clinical trial, n=25, Fitzpatrick I–IV. Histological collagen remodelling and elastosis reduction confirmed across all participants following 6 IPL sessions with adjunctive skincare. PMID: 12928821.
Li, Y.-H., Wu, Y., Chen, J. Z. S., Zhu, X., Xu, Y.-Y., Chen, J., Dong, G.-H., Gao, X.-H., & Chen, H.-D. (2010). A split-face study of intense pulsed light on photoaging skin in Chinese population. Lasers in Surgery and Medicine, 42(2), 185–191. https://doi.org/10.1002/lsm.20889
Split-face RCT, n=24. Histological increase in collagen fibres and melanin reduction on treated side. Global photoaging score improved from 3.02 to 1.22; untreated side unchanged. PMID: 20166160.
Cho, E. B., Park, H., Park, E. J., Kwon, I. H., Kim, S. S., Kim, K. H., Kim, K. J., & Park, H. R. (2011). Effect of intense pulsed light on rat skin. Dermatologic Surgery, 38(3), 430–436. https://doi.org/10.1111/j.1524-4725.2011.02213.x
Animal study. IPL increased dermal collagen fibre diameter. Longer inter-session intervals (3 weeks vs 1 week) produced greater collagen fibre thickness, supporting minimum 4-week session spacing. PMID: 22092593.
El-Domyati, M., El-Ammawi, T. S., Medhat, W., Moawad, O., Mahoney, M. G., & Uitto, J. (2014). Expression of transforming growth factor-β after different non-invasive facial rejuvenation modalities. International Journal of Dermatology, 54(4), 396–404. https://doi.org/10.1111/ijd.12435
Comparative RCT, n=36, Fitzpatrick III–IV. IPL did NOT produce a statistically significant increase in TGF-β or new collagen synthesis compared to baseline, in contrast to radiofrequency, ELOS, and laser modalities. Key negative finding limiting IPL collagen remodelling claims. PMID: 25514823.
Handler, M. Z., Bloom, B. S., & Goldberg, D. J. (2017). IPL vs PDL in treatment of facial erythema: A split-face study. Journal of Cosmetic Dermatology, 16(4), 450–453. https://doi.org/10.1111/jocd.12365
Split-face RCT, n=15, using Sciton BBL specifically. BBL and pulsed dye laser equally effective in reducing facial erythema at non-purpuric settings. The only peer-reviewed study using the Sciton BBL device specifically. PMID: 28752575.
Sales, A. F. S., Pandolfo, I. L., de Almeida Cruz, M., Parisi, J. R., Garcia, L. A., Martignago, C. C. S., Renno, A. C. M., & Vassão, P. G. (2021). Intense pulsed light on skin rejuvenation: A systematic review. Archives of Dermatological Research, 314(9), 823–838. https://doi.org/10.1007/s00403-021-02283-2
First PRISMA-registered systematic review of IPL for skin rejuvenation (PROSPERO CRD42021237817). 16 studies, n=637, Fitzpatrick I–IV. Confirms IPL efficacy across telangiectasia, erythema, lentigines, and hyperpigmentation. Critical finding: 9 of 16 studies rated low methodological quality; no consensus on parameters. PMID: 34609598.
Fan, B., & Yu, R. (2026). Comprehensive facial skin rejuvenation with long-term regular intense pulsed light therapy: A real-world study. Journal of Cosmetic Dermatology, 25(2), e70691. https://doi.org/10.1111/jocd.70691
Retrospective real-world study, n=236, ≥6 IPL sessions, VISIA imaging, 2020–2025. Treatment regularity (OR=13.62) and total session number (OR=3.80) independently predict good outcomes. Fitzpatrick IV significantly lower response rates (OR=0.12, p=0.001). Largest real-world IPL series to date. PMID: 41582594.
BBL Gene Expression — Pilot Study
Chang, A. L. S., Bitter, P. H., Qu, K., Lin, M., Rapicavoli, N. A., & Chang, H. Y. (2013). Rejuvenation of gene expression pattern of aged human skin by broadband light treatment: A pilot study. Journal of Investigative Dermatology, 133(2), 394–402. https://doi.org/10.1038/jid.2012.287
Pilot study, n=5, Fitzpatrick II–III, forearm skin only. 1,293 of 2,265 age-altered gene expression patterns shifted toward young skin patterns following 3 BBL treatments. Sciton-funded; co-author commercial disclosure; no independent replication. Not suitable for patient-facing ‘genetic reversal’ claims. Peer-reviewed and PubMed-indexed. PMID: 22931923.
IPL in Rosacea — Vascular Indications
Husein-ElAhmed, H., & Steinhoff, M. (2021). Light-based therapies in the management of rosacea: A systematic review with meta-analysis. International Journal of Dermatology, 61(2), 216–225. https://doi.org/10.1111/ijd.15680
Systematic review and meta-analysis, 12 studies. IPL effectiveness comparable to pulsed dye laser for erythematotelangiectatic rosacea; overall quality of evidence rated low-to-moderate. Multiple sessions required. PMID: 34089264.
Martignago, C. C. S., Bonifacio, M., Ascimann, L. T., Vassão, P. G., Parisi, J. R., Renno, A. P., Garcia, L. A., Ribeiro, D. A., & Renno, A. C. M. (2024). Efficacy and safety of intense pulsed light in rosacea: A systematic review. Indian Journal of Dermatology, Venereology and Leprology, 90(5), 599–605. https://doi.org/10.25259/IJDVL_1029_2022
Systematic review, 14 studies, Fitzpatrick I–IV. Confirms positive effects of IPL on telangiectasia and erythema in rosacea with transitory adverse effects. All trials show methodological limitations; further high-quality RCTs needed. PMID: 39152889.
Melasma & Hyperpigmentation — IPL Near-Contraindication
Passeron, T., Genedy, R., Salah, L., Fusade, T., Kositratna, G., Laubach, H.-J., Marini, L., & Badawi, A. (2019). Laser treatment of hyperpigmented lesions: Position statement of the European Society of Laser in Dermatology. Journal of the European Academy of Dermatology and Venereology, 33(6), 987–1005. https://doi.org/10.1111/jdv.15497
Consensus position statement, European Society of Laser Dermatology (ESLD). Establishes that IPL/BBL can worsen melasma and trigger post-inflammatory hyperpigmentation; documents BBL/IPL as not first-line for melasma. Clinical governance basis for the near-contraindication policy across the Avery BBL suite. PMID: 30873649.
Isotretinoin & Light-Based Treatments — No Washout Required
Spring, L. K., Krakowski, A. C., Alam, M., Bhatia, A., Brauer, J., Cohen, J., Del Rosso, J. Q., Diaz, L., Dover, J., Eichenfield, L. F., Gurtner, G. C., Hanke, C. W., Jahnke, M. N., Kelly, K. M., Khetarpal, S., Kinney, M. A., Levy, M. L., Leyden, J., Longaker, M. T., … Zaenglein, A. L. (2017). Isotretinoin and timing of procedural interventions: A systematic review with consensus recommendations. JAMA Dermatology, 153(8), 802–809. https://doi.org/10.1001/jamadermatol.2017.2077
Systematic review with consensus panel, 1,485 procedures. Insufficient evidence to support delaying non-ablative laser, light-based, or IPL treatments in patients on or recently completing isotretinoin. Basis for the Avery protocol position that no washout is required for BBL. PMID: 28658462.
Waldman, A., Bolotin, D., Arndt, K. A., Dover, J. S., Geronemus, R. G., Chapas, A., Iyengar, S., Kilmer, S. L., Krakowski, A. C., Lawrence, N., Prather, H. B., Rohrer, T. E., Schlosser, B. J., Kim, J. Y. S., Shumaker, P. R., Spring, L. K., & Alam, M. (2017). ASDS guidelines task force: Consensus recommendations regarding the safety of lasers, dermabrasion, chemical peels, energy devices, and skin surgery during and after isotretinoin use. Dermatologic Surgery, 43(10), 1249– 1262. https://doi.org/10.1097/DSS.0000000000001166
American Society for Dermatologic Surgery (ASDS) consensus guidelines. Concludes insufficient evidence to delay non-ablative lasers, vascular lasers, IPL, or light-based treatments during or after isotretinoin. Corroborates Spring et al. (2017). PMID: 28498204.
Latifaltojar, R., Pour Mohammad, A., & Goodarzi, A. (2024). Keloid formation and any skin complications in patients treated with isotretinoin and undergone any skin-related procedures. Journal of Cosmetic Dermatology, 24(2), e16680. https://doi.org/10.1111/jocd.16680
Systematic review, 34 studies, n=1,563. Confirms insufficient evidence to support delaying non-ablative fractional lasers, IPL, and superficial peels. Corroborates Spring et al. (2017) and Waldman et al. (2017). PMID: 39568321.
He, S.-X., Wang, Y., Wang, J., Tang, L., Yang, L., & Ye, F.-L. (2025). Isotretinoin combined laser/light-based treatments versus isotretinoin alone for the treatment of acne vulgaris: A meta-analysis. Journal of Cosmetic Dermatology, 24(1), e16639. https://doi.org/10.1111/jocd.16639
Meta-analysis, 6 RCTs, n=285. Isotretinoin combined with laser/light therapy outperformed isotretinoin alone in clinical improvement without increased adverse events. No significant difference in complications between combined and isotretinoin-only groups. Most recent meta-analytic evidence on this topic. PMID: 39509291.
Gold Therapy & Laser-Induced Chrysiasis
Trotter, M. J., Tron, V. A., Hollingdale, J., & Rivers, J. K. (1995). Localized chrysiasis induced by laser therapy. Archives of Dermatology, 131(12), 1411– 1414. https://pubmed.ncbi.nlm.nih.gov/7492130/
Case report. Established that Q-switched laser irradiation induces localized chrysiasis in patients with systemic gold therapy by altering dermal gold deposit structure. Gold deposits persist indefinitely in the dermis. PMID: 7492130. No DOI available (predates DOI assignment for this journal era).
Cohen, P. R., & Ross, E. V. (2015). Q-switched alexandrite laser-induced chrysiasis. Journal of Clinical and Aesthetic Dermatology, 8(9), 48– 53. https://pmc.ncbi.nlm.nih.gov/articles/PMC4587895/
Case report and literature review. Laser-induced chrysiasis described in patients who received systemic gold therapy, can occur decades after gold treatment was discontinued. Basis for the requirement to specifically ask about gold therapy history in all patients. PMID: 26430491. Full text freely available via PubMed Central.
Additional research
Retrospective Evaluation of the Long-term Effects of BroadBand Light (BBLTM )Therapy.
Notes on Evidence Quality & Use
All references in this list are peer-reviewed and published in indexed scientific journals. Evidence quality ratings reflect the study design hierarchy: systematic reviews and meta-analyses provide the highest level of evidence; RCTs provide moderate-to-high evidence; comparative studies, pilot studies, and case reports provide lower-level evidence and are used accordingly in the clinical training documents.
Manufacturer-supported studies (Chang et al. 2013, Handler et al. 2017) are included with explicit disclosure of funding source and commercial author disclosures as required for AHPRA-compliant clinical communication. These studies are treated as lower-strength evidence and are not used as the sole basis for any clinical protocol position.
PubMed records verified March 2026. DOI links are functional at time of compilation; journal access may require institutional subscription for full text.
All references are cited in APA 7th edition format. Where available, hyperlinked DOIs are provided for direct article access. References are verified against PubMed records (pubmed.ncbi.nlm.nih.gov). All cited articles are peer-reviewed and indexed in PubMed or equivalent scholarly databases, with the exception of Anderson & Parrish (1983), which predates PubMed indexing and is retrievable via DOI. Evidence quality notes are included where relevant to clinical application.
Blue Light Mechanism & Photoinactivation
Ashkenazi, H., Malik, Z., Harth, Y., & Nitzan, Y. (2003). Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunology and Medical Microbiology, 35(1), 17–24. https://doi.org/10.1111/j.1574...
Boyd, J. M., Lewis, K. A., Mohammed, N., Desai, P., Purdy, M., Li, W.-H., Fourre, T., Miksa, D., Crane, S., Southall, M., & Fassih, A. (2019). Propionibacterium acnes susceptibility to low-level 449 nm blue light photobiomodulation. Lasers in Surgery and Medicine, 51(8), 727–734. https://doi.org/10.1002/lsm.23...
Dai, T., Gupta, A., Murray, C. K., Vrahas, M. S., Tegos, G. P., & Hamblin, M. R. (2012). Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? Drug Resistance Updates, 15(4), 223–236. https://doi.org/10.1016/j.drup...
Elman, M., Slatkine, M., & Harth, Y. (2003). The effective treatment of acne vulgaris by a high-intensity, narrow band 405–420 nm light source. Journal of Cosmetic and Laser Therapy, 5(2), 111–117. https://pubmed.ncbi.nlm.nih.go...
Intense Pulsed Light & Light-Based Therapy for Acne
Amiri, R., Khalili, M., Mohammadi, S., Iranmanesh, B., & Aflatoonian, M. (2022). Treatment protocols and efficacy of light and laser treatments in post-acne erythema. Journal of Cosmetic Dermatology, 21(2), 648–656. https://doi.org/10.1111/jocd.1...
Austin, E., Geisler, A. N., Nguyen, J., Kohli, I., Hamzavi, I., Lim, H. W., & Jagdeo, J. (2021). Visible light. Part I: Properties and cutaneous effects of visible light. Journal of the American Academy of Dermatology, 84(5), 1219–1231. https://doi.org/10.1016/j.jaad...
Babilas, P., Schreml, S., Szeimies, R.-M., & Landthaler, M. (2010). Intense pulsed light (IPL): A review. Lasers in Surgery and Medicine, 42(2), 93–104. https://doi.org/10.1002/lsm.20...
Cai, Y., Zhu, Y., Wang, Y., & Xiang, W. (2022). Intense pulsed light treatment for inflammatory skin diseases: A review. Lasers in Medical Science, 37(8), 3085–3105. https://doi.org/10.1007/s10103...
Huang, Q., Chen, D., Pan, S., Hu, M., Wang, P., Wang, H., Fan, W., Yang, X., & He, Y. (2022). Efficacy of alpha hydroxy acid combined with intense pulsed light in the treatment of acne vulgaris: A meta-analysis. Journal of Cosmetic Dermatology, 21(11), 5642–5650. https://doi.org/10.1111/jocd.1...
Jafarzadeh, A., Heidari, S., Omid, R., & Goodarzi, A. (2025). Systematic review of vascular lasers for the treatment of inflammatory active acne vulgaris. Lasers in Medical Science, 40(1), Article 168. https://doi.org/10.1007/s10103...
Nouri, K., & Villafradez-Diaz, L. M. (2005). Light/laser therapy in the treatment of acne vulgaris. Journal of Cosmetic Dermatology, 4(4), 318–320. https://doi.org/10.1111/j.1473...
Piccolo, D., Kostaki, D., Dianzani, C., Crisman, G., & Conforti, C. (2022). Effective intense pulsed light protocol in the treatment of moderate to severe acne vulgaris of the chest and back. The Journal of Clinical and Aesthetic Dermatology, 15(3), 22–25. https://pubmed.ncbi.nlm.nih.go...
Zdrada, J., Stolecka-Warzecha, A., Odrzywolek, W., Deda, A., Blońska-Fajfrowska, B., & Wilczyński, S. (2021). The use of light in the treatment of acne vulgaris — A review. Journal of Cosmetic Dermatology, 20(12), 3788–3792. https://doi.org/10.1111/jocd.1...
Zhang, X., Cui, W., Chen, M., & Li, M. (2026). Dual-filter IPL vs. LED phototherapy combined with systemic therapy for moderate-to-severe acne in Asian patients. Frontiers in Medicine, 12, Article 1742480. https://doi.org/10.3389/fmed.2...
Nd:YAG 1064 nm for Acne — ClearSilk Step 4 Evidence
Albalat, W., Ehab, R., AbouHadeed, M. H., Abd Allah, T. N., & Essam, R. (2024). Combined low-dose isotretinoin and long-pulsed Nd:YAG laser in the treatment of post-acne erythema. Archives of Dermatological Research, 316(7), Article 359. https://doi.org/10.1007/s00403...
Artzi, O., Koren, A., Shehadeh, W., & Friedman, O. (2021). Quasi long-pulsed 1064 nm Nd:YAG (micro pulsed) technology for the treatment of active acne: A case series. Journal of Cosmetic Dermatology, 20(7), 2102–2107. https://doi.org/10.1111/jocd.1...
Mohamed, E. M., Abdel-Aleem, H. L., Elazab, G. M. H., & Rageh, M. A. (2025). Comparative efficacy and safety of 577-nm diode laser versus 1064-nm Nd:YAG laser for inflammatory acne vulgaris: A split-face randomized study. Lasers in Medical Science, 40(1), Article 422. https://doi.org/10.1007/s10103...
Moftah, N. H., Mansour, A. M., & Ibrahim, S. M. A. (2022). Clinical evaluation of efficacy of intralesional platelet-rich plasma injection versus 1064 nm long-pulsed Neodymium:YAG laser in the treatment of inflammatory acne vulgaris: A prospective randomized split-face comparative study. Lasers in Medical Science, 37(5), 2471–2478. https://doi.org/10.1007/s10103...
Notes on Evidence Quality & Use
All references in this list are peer-reviewed and published in indexed scientific journals. Evidence quality ratings reflect the study design hierarchy: systematic reviews and meta-analyses provide the highest level of evidence; RCTs provide moderate-to-high evidence; comparative studies, pilot studies, and case reports provide lower-level evidence and are used accordingly in the clinical training documents.
Manufacturer-supported studies (Chang et al. 2013, Handler et al. 2017) are included with explicit disclosure of funding source and commercial author disclosures as required for AHPRA-compliant clinical communication. These studies are treated as lower-strength evidence and are not used as the sole basis for any clinical protocol position.
PubMed records verified March 2026. DOI links are functional at time of compilation; journal access may require institutional subscription for full text.
References
Each entry notes what kind of study it was, so you can judge how much weight to give it. Links go to the source.
1. van Zuijlen, P. P., de Vries, H. J., Lamme, E. N., Coppens, J. E., van Marle, J., Kreis, R. W., & Middelkoop, E. (2002). Morphometry of dermal collagen orientation by Fourier analysis is superior to multi-observer assessment. The Journal of Pathology, 198(3), 284–291. https://doi.org/10.1002/path.1219
What this is: A laboratory study comparing an objective computer method for measuring collagen direction against expert human assessment, using 271 images from scar and normal skin biopsies in 65 patients. It's the study that established you can measure this reliably rather than just eyeball it.
2. Verhaegen, P. D., Van Zuijlen, P. P., Pennings, N. M., Van Marle, J., Niessen, F. B., Van Der Horst, C. M., & Middelkoop, E. (2009). Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis. Wound Repair and Regeneration, 17(5), 649–656. https://doi.org/10.1111/j.1524-475X.2009.00533.x
What this is: An analysis of 194 tissue samples — normal skin plus three scar types — using the method above. It found collagen arranged more in parallel in all three scar types compared with normal skin. A good sample size for this kind of work.
3. Zhang, L., Liu, C., & Li, L. (2026). An overview of the mechanisms of fractional CO₂ laser in scar treatment. Lasers in Medical Science, 41(1), Article 42. https://doi.org/10.1007/s10103-026-04846-z
What this is: A 2026 review pulling together the laboratory and clinical research on how this laser works, step by step. Limitation, stated by its own authors: it is a narrative review, not a systematic one, and much of the evidence it summarises comes from animal models and normal skin rather than human scar tissue. Used here for mechanism, not for how well treatment works.
4. Manstein, D., Herron, G. S., Sink, R. K., Tanner, H., & Anderson, R. R. (2004). Fractional photothermolysis: A new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers in Surgery and Medicine, 34(5), 426–438. https://doi.org/10.1002/lsm.20048
What this is: The original paper describing the fractional principle. A landmark study — the approach it introduced is now standard across the field and has held up for twenty years. It was not a scar study: the principle was established on ordinary skin and applied to scars later.
5. Ji, Q., Luo, L., Ni, J., Pu, X., Qiu, H., & Wu, D. (2025). Fractional CO₂ laser to treat surgical scars: A systematic review and meta-analysis on optimal timing. Journal of Cosmetic Dermatology, 24(1), Article e16708. https://doi.org/10.1111/jocd.16708
What this is: The largest pooled analysis of CO₂ laser for surgical scars — 14 controlled trials, 9 of them randomised, 492 participants or scars. Limitations, several: results varied widely between the studies pooled; the authors rated the risk of bias as high for how patients were assigned to groups and for whether assessors knew which treatment they were scoring; and the pattern of published results suggests negative studies may be missing. The trials also measured their starting point differently — some from the date of surgery, some from suture removal — so the "one month" cut-off is softer than it looks. Acne, burn, tattoo and birthmark studies were excluded by design.
6. Argobi, Y., Tobeigei, F., & Alasiri, F. I. (2026). Fractional CO₂ laser versus microneedling radiofrequency for post-acne scarring: A meta-analysis of RCTs. Journal of Cosmetic Dermatology, 25(3), Article e70765. https://doi.org/10.1111/jocd.70765
What this is: A pooled analysis of eight randomised trials, 249 patients — randomised trials are the strongest single study design, so this is good-quality evidence. Limitation: the trials are small and follow-up is short, and the authors call for longer studies with consistent outcome measures.
7. Hashad, Y., Gharib, F., & Rafie, M. (2025). Effect of CO₂ fractional laser intervention versus hyaluronidase injection in early scar treatment: A randomized controlled study. Lasers in Medical Science, 40(1), Article 289. https://doi.org/10.1007/s10103-025-04538-0
What this is: A randomised trial of 60 patients (56 completed) at a single centre in Egypt, treating scars two to four weeks old, with six months of follow-up. Limitations: small, one centre, one population, and people with a history of keloid or raised scarring were excluded — so it doesn't tell us about them.
8. Hang, X., & Lim, D. S. (2025). A novel peel to prevent post-inflammatory hyperpigmentation after CO₂ resurfacing for acne scars. Journal of Cosmetic Dermatology, 24(8), Article e70366. https://doi.org/10.1111/jocd.70366 (Correction published 2025, Journal of Cosmetic Dermatology, 24(9), Article e70469. https://doi.org/10.1111/jocd.70469)
What this is: A randomised, assessor-blinded study of 29 patients with deeper skin tones (Fitzpatrick III–V), run at QIMR Berghofer and Cutis Clinic in Queensland, testing whether a peel used before and after treatment reduces pigmentation. It did. Limitations, and they are serious: the work was partly funded by Dermalogica, which makes the peel that was tested, so the finding carries a commercial interest; the journal subsequently published a correction asking that the product's brand name be removed from the article to avoid commercial emphasis; the study is small and was run at a single centre; and the peel made no difference to how much the scars themselves improved. We have not used it to support any claim about treatment working.
A note on how we use research
We only cite studies we have read in full, not just the summary. Where a study has a weakness, we state it next to the claim it supports rather than at the end. We avoid relying on research funded or conducted by the companies that make the devices or products involved. One study cited here was partly funded by a product manufacturer; we have said so in its reference entry, and we have not used it to support any claim about how well treatment works. Where the evidence is thin, we say so.
Medical evidence changes. This document reflects published research as at September 2026.
Avery Aesthetics · Ground Floor, 14 Watt Street, Newcastle NSW 2300 · (02) 4002 4150 · [email protected]
Results vary and may differ for other patients. All procedures carry inherent risk. Suitability, the likely number of sessions and the risks involved are discussed and confirmed at consultation.
Dr Gary Avery FRACS · AHPRA MED0001633092
All references are cited in APA 7th edition format. Where available, hyperlinked DOIs are provided for direct article access. References are verified against PubMed records (pubmed.ncbi.nlm.nih.gov). All cited articles are peer-reviewed and indexed in PubMed or equivalent scholarly databases. Evidence quality notes are included where relevant to clinical application.
Mechanism of Action — Muscle Tissue
Kinney, B. M., Bernardy, J., & Jarošová, R. (2023). Novel technology for facial muscle stimulation combined with synchronized radiofrequency induces structural changes in muscle tissue: Porcine histology study. Aesthetic Surgery Journal, 43(8), 920–927. https://doi.org/10.1093/asj/sjad053
Kent, D. E., Fritz, K., Salavastru, C., Jarosova, R., & Bernardy, J. (2024). First evidence of cutaneous remodelling induced by synchronized radiofrequency aided by high-intensity facial muscle stimulation: Porcine animal model. Dermatologic Surgery, 50(2), 178–181. https://doi.org/10.1097/DSS.0000000000004028
Mechanism of Action — Submental Fat Reduction
Robb, C. W., Bernardy, J., Jarošová, R., & Hodkovicova, N. (2024). Novel applicator utilizing HIFES and enhanced synchronized radiofrequency+ for subcutaneous fat reduction: Porcine model study. Lasers in Surgery and Medicine, 57(1), e23854. https://doi.org/10.1002/lsm.23854
Goldberg, D. J. (2025). Adipocyte apoptosis following a novel method for double chin reduction: A pilot human histology study. Journal of Cosmetic Dermatology, 24(1), e16643. https://doi.org/10.1111/jocd.16643
Clinical Efficacy — Facial Rejuvenation
Goldberg, D. J., & Lal, K. (2024). Treatment with synchronized radiofrequency and facial muscle stimulation: Histologic analysis of human skin for changes in collagen and elastin fibers. Journal of Cosmetic Dermatology, 23(5), 1620–1628. https://doi.org/10.1111/jocd.16273
Gentile, R., & Halaas, Y. (2024). Novel approach to facial rejuvenation by treating cutaneous and soft tissue for wrinkles reduction: First experience from multicenter clinical trial. Facial Plastic Surgery & Aesthetic Medicine, 26(1), 1–6. https://doi.org/10.1089/fpsam.2023.0015
Additional research
Novel Applicator Utilizing HIFES and Enhanced Synchronized Radiofrequency+ for Subcutaneous Fat Reduction: Porcine Model Study. (Manufacturer PDF — Robb et al. 2024; peer-reviewed citation above)
Adipocyte Apoptosis Following a Novel Method for Double Chin Reduction: A Pilot Human Histology Study. (Manufacturer PDF — Goldberg 2025; peer-reviewed citation above)
Simultaneous Emission of Synchronized Radiofrequency and HIFES™ for Non-invasive Facial Rejuvenation: The Mechanism of Action. (BTL Industries mechanism of action document — not a peer-reviewed publication)
Simultaneous Emission of Synchronized Radiofrequency and HIFES™ for Non-invasive Facial Rejuvenation. (BTL Industries mechanism of action summary — not a peer-reviewed publication)
Facial Ageing, Anatomy and EMFACE: An Evidence-Based Educational Overview.
(BTL Industries educational overview — not a peer-reviewed publication)
Notes on Evidence Quality & Use
All references in this section are peer-reviewed and published in indexed scientific journals. The majority of mechanistic studies are conducted in porcine animal models by researchers with disclosed commercial affiliations with BTL Industries. These studies are treated as lower-strength evidence and are not used as the sole basis for any clinical protocol position. Human clinical data (Goldberg 2025, Gentile & Halaas 2024) provides supporting evidence for clinical application. Independent replication of these findings in adequately powered human RCTs remains limited at this time.
PubMed records verified March 2026. DOI links are functional at time of compilation; journal access may require institutional subscription for full text
All references are cited in APA 7th edition format. Where available, hyperlinked DOIs are provided for direct article access. References are verified against PubMed records (pubmed.ncbi.nlm.nih.gov). All cited articles are peer-reviewed and indexed in PubMed or equivalent scholarly databases. Evidence quality notes are included where relevant to clinical application.
Mechanism of Action — Fat Apoptosis
Goldberg, D. J. (2021). Deletion of adipocytes induced by a novel device simultaneously delivering synchronized radiofrequency and HIFEM: Human histological study. Journal of Cosmetic Dermatology, 20(4), 1104–1109. https://doi.org/10.1111/jocd.13970
Goldberg, D. J. (2024). Induction of fat apoptosis by a combination of synchronized radiofrequency and HIFEM technology: Human histology study. Journal of Cosmetic Dermatology, 23(3), 812–817. https://doi.org/10.1111/jocd.16197
Foundational Clinical Evidence — Abdominal Body Contouring
Kinney, B. M., & Lozanova, P. (2019). High intensity focused electromagnetic therapy evaluated by magnetic resonance imaging: Safety and efficacy study of a dual tissue effect based non-invasive abdominal body shaping. Lasers in Surgery and Medicine, 51(1), 40–46. https://doi.org/10.1002/lsm.23024
Samuels, J. B., & Mamber, S. (2022). Radiofrequency heating and high-intensity focused electromagnetic treatment delivered simultaneously: The first sham-controlled randomized trial. Plastic and Reconstructive Surgery, 149(6), 1400–1409. https://doi.org/10.1097/PRS.0000000000009179
Systematic Review Evidence
Kohan, J., Vyas, K., Erotocritou, M., Robb, C. W., & Silberstein, A. (2024). High-intensity focused electromagnetic (HIFEM) energy with and without radiofrequency for noninvasive body contouring: A systematic review. Aesthetic Plastic Surgery, 48(3), 1156–1165. https://doi.org/10.1007/s00266-023-03730-3
Functional Wellness — Musculoskeletal Applications
Katz, B., & Bard, R. (2021). Simultaneous application of HIFEM and synchronized radiofrequency for improvement of musculoskeletal system function — Preliminary data. Journal of Cosmetic Dermatology, 20(10), 3083–3090. https://doi.org/10.1111/jocd.14466
Additional research
Effect of HIFEM Application on Musculoskeletal System: Evaluation of Musculoskeletal System Improvement — Preliminary Data. (BTL Industries clinical summary document — not a peer-reviewed publication)
Simultaneous Application of HIFEM Procedure and Radiofrequency for Improvement of Muscular System Function — Preliminary Data. (BTL Industries clinical summary document — not a peer-reviewed publication)
EMSCULPT NEO — The Mechanism of Action: Simultaneous emission of synchronized radiofrequency and magnetic fields in a single applicator for fat elimination and muscle building. (BTL Industries mechanism of action summary — not a peer-reviewed publication)
EMSCULPT NEO: Simultaneous emission of novel Synchronized Radiofrequency and HIFEM in a single applicator for fat elimination and muscle building. (BTL Industries mechanism of action full paper — not a peer-reviewed publication)
Functional Wellness: Enhance Muscle & Joint Function and Boost Recovery to Promote Functional Wellness.
(BTL Industries functional wellness overview — not a peer-reviewed publication)
Notes on Evidence Quality & Use
All references in this section are peer-reviewed and published in indexed scientific journals. The majority of clinical trials were conducted by researchers with disclosed commercial affiliations with BTL Industries. The sham-controlled RCT (Samuels & Mamber, 2022) represents the strongest level of evidence in this field. The systematic review (Kohan et al., 2024) provides a balanced assessment including critical limitations of the published literature. Manufacturer-supported studies are treated as lower-strength evidence and are not used as the sole basis for any clinical protocol position.
PubMed records verified March 2026. DOI links are functional at time of compilation; journal access may require institutional subscription for full text.
EXION Body Research
All references are cited in APA 7th edition format. Where available, hyperlinked DOIs are provided for direct article access. References are verified against PubMed records (pubmed.ncbi.nlm.nih.gov). All cited articles are peer-reviewed and indexed in PubMed or equivalent scholarly databases. Evidence quality notes are included where relevant to clinical application.
Cellulite & Body Contouring — Foundational RF Mechanism
Franco, W., Kothare, A., Ronan, S. J., Grekin, R. C., & McCalmont, T. H. (2010). Hyperthermic injury to adipocyte cells by selective heating of subcutaneous fat with a novel radiofrequency device: Feasibility studies. Lasers in Surgery and Medicine, 42(5), 361–370. https://doi.org/10.1002/lsm.20925
Radiofrequency + Ultrasound Combination — Mechanism of Action
Alizadeh, Z., Halabchi, F., Mazaheri, R., Abolhasani, M., & Tabesh, M. (2016). Review of the mechanisms and effects of noninvasive body contouring devices on cellulite and subcutaneous fat. International Journal of Endocrinology and Metabolism, 14(4), e36727. https://doi.org/10.5812/ijem.36727
Cellulite — Targeted Pressure Energy + RF (Emtone: Complementary Device)
Weiss, R. A., & Bernardy, J. (2020). Induction of fat apoptosis by a non-thermal device: Mechanism of action of monopolar radiofrequency in a porcine model. Lasers in Surgery and Medicine, 52(3), 189–193. https://doi.org/10.1002/lsm.23127
Additional research
EXION Body and Cellulite.
(BTL Industries clinical document — not a peer-reviewed publication)
Notes on Evidence Quality & Use
All references in this section are peer-reviewed and published in indexed scientific journals. EXION Body is a relatively recent device and dedicated published clinical trials are limited at time of compilation (March 2026). The references included represent the best available mechanistic and foundational evidence supporting the technologies incorporated in EXION Body. Practitioners are encouraged to supplement this library with device-specific clinical data as it becomes available. The manufacturer's mechanism of action documentation (linked above) should be reviewed in conjunction with these peer-reviewed references.
PubMed records verified March 2026. DOI links are functional at time of compilation; journal access may require institutional subscription for full text.
All references are cited in APA 7th edition format. Where available, hyperlinked DOIs are provided for direct article access. References are verified against PubMed records (pubmed.ncbi.nlm.nih.gov). All cited articles are peer-reviewed and indexed in PubMed or equivalent scholarly databases. Evidence quality notes are included where relevant to clinical application.
Foundational Mechanism — RF + Ultrasound Combination and Hyaluronic Acid Stimulation
Weiss, R., Weiss, M., Beasley, K., Munavalli, G., & Bernardy, J. (2022). Simultaneous delivery of radiofrequency and targeted ultrasound for enhanced hyaluronic acid production in the skin. Journal of Cosmetic Dermatology, 21(12), 6605–6613. https://doi.org/10.1111/jocd.15234
Lee, H. J., Seo, S. R., Yoon, M. S., Song, J. Y., Lee, E. Y., & Lee, S. E. (2016). Microneedle fractional radiofrequency increases epidermal hyaluronan and reverses age-related epidermal dysfunction. Lasers in Surgery and Medicine, 48(1), 140–148. https://doi.org/10.1002/lsm.22421
Short-Term Clinical Outcomes
Duncan, D. I. (2023). Short-term impact of EXION Face: Combined monopolar radiofrequency and targeted ultrasound for facial skin rejuvenation. Aesthetic Surgery Journal Open Forum, 5, ojad083. https://doi.org/10.1093/asjof/ojad083
Additional research
The Short Term Impact of EXION Face.
(BTL Industries clinical document — not a peer-reviewed publication)
Notes on Evidence Quality & Use
All references in this section are peer-reviewed and published in indexed scientific journals. Published clinical evidence specific to the EXION Face device is emerging. The foundational mechanism study (Weiss et al., 2022) represents the primary peer-reviewed evidence for HA stimulation via simultaneous RF + ultrasound. Independent replication of EXION Face outcomes in adequately powered RCTs is not yet available at time of compilation (March 2026).
PubMed records verified March 2026. DOI links are functional at time of compilation; journal access may require institutional subscription for full text.
All references are cited in APA 7th edition format. Where available, hyperlinked DOIs are provided for direct article access. References are verified against PubMed records (pubmed.ncbi.nlm.nih.gov). All cited articles are peer-reviewed and indexed in PubMed or equivalent scholarly databases. Evidence quality notes are included where relevant to clinical application.
Foundational Mechanism — Fractional RF Microneedling
Hantash, B. M., Ubeid, A. A., Chang, H., Kafi, R., & Renton, B. (2009). Bipolar fractional radiofrequency treatment induces neoelastogenesis and neocollagenesis. Lasers in Surgery and Medicine, 41(1), 1–9. https://doi.org/10.1002/lsm.20731
Gold, M. H., Biron, J. A., & Sensing, W. (2011). Clinical and histologic evaluation of a novel ablative fractional resurfacing device for treatment of skin wrinkles and photoaged skin. Journal of Drugs in Dermatology, 10(2), 138–143. https://pubmed.ncbi.nlm.nih.gov/21283830/
Deep Tissue Penetration — Novel RF Mechanism
Mulholland, R. S. (2022). Revolutionary fractional RF microneedling enables deep tissue penetration without full needle insertion for skin rejuvenation and fat reduction. Journal of Cosmetic Dermatology, 21(10), 4287–4295. https://doi.org/10.1111/jocd.15191
Systematic Review — Fractional RF Microneedling Efficacy and Safety
Alster, T. S., & Graham, P. M. (2018). Microneedling: A review and practical guide. Dermatologic Surgery, 44(3), 397–404. https://doi.org/10.1097/DSS.0000000000001248
Alexiades, M., Berube, D., & Goldman, M. P. (2021). Fractional microneedle radiofrequency — mechanism of action and assessment of safety, effectiveness in treatment, and possible side effects based on a review of scientific literature. Journal of Drugs in Dermatology, 20(11), 1262–1268. https://doi.org/10.36849/JDD.6283
Additional research
Revolutionary Fractional RF Microneedling Enables Deep Tissue Penetration Without Full Needle Insertion for Skin Rejuvenation and Fat Reduction. (Manufacturer PDF — Mulholland 2022; peer-reviewed citation above)
EXION Fractional RF Applicator: Mechanism of Action Paper. (BTL Industries one-page mechanism summary — not a peer-reviewed publication)
Simultaneous Delivery of Radiofrequency and Targeted Ultrasound for Enhanced Hyaluronic Acid Production in the Skin. (Manufacturer PDF — Weiss et al. 2022; peer-reviewed citation in EXION Face section above)
EXION Face & Body Applications: Mechanism of Action Paper. (BTL Industries one-page mechanism summary — not a peer-reviewed publication)
Fractional microneedle radiofrequency — mechanism of action and assessment of safety, effectiveness in the treatment, and possible side effects based on a review of scientific literature.
(Manufacturer PDF — Alexiades et al. 2021; peer-reviewed citation above)
Notes on Evidence Quality & Use
All references in this section are peer-reviewed and published in indexed scientific journals. The mechanistic literature for fractional RF microneedling is well-established across multiple independent research groups. Device-specific evidence for EXION RF is emerging; where EXION-specific studies are included, commercial authorship disclosures are noted. Broader fractional RF evidence (Alster & Graham, 2018; Alexiades et al., 2021) provides independent validation of the technology class. Independent head-to-head comparisons between EXION RF and other fractional RF devices are not yet available.
PubMed records verified March 2026. DOI links are functional at time of compilation; journal access may require institutional subscription for full text.
All references are cited in APA 7th edition format. Where available, hyperlinked DOIs are provided for direct article access. References are verified against PubMed records (pubmed.ncbi.nlm.nih.gov). All cited articles are peer-reviewed and indexed in PubMed or equivalent scholarly databases. Evidence quality notes are included where relevant to clinical application.
Foundational Science — Fractional CO₂ Laser
Laubach, H. J., Tannous, Z., Anderson, R. R., & Manstein, D. (2006). Skin responses to fractional photothermolysis. Lasers in Surgery and Medicine, 38(2), 142–149. https://doi.org/10.1002/lsm.20254
Laser Scar Revision
Hultman, C. S., Friedstat, J. S., Edkins, R. E., Cairns, B. A., & Meyer, A. A. (2014). Laser resurfacing and remodeling of hypertrophic burn scars: The results of a large, prospective, before-after cohort study, with long-term follow-up. Annals of Surgery, 260(3), 519–532. https://doi.org/10.1097/SLA.0000000000000893
Renner, R., & Erfurt-Berge, C. (2022). Laser revision of scars. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK539686/
Hybrid Fractional Laser — HALO Clinical Evidence
Pozner, J. N., & DiBernardo, B. E. (2018). Hybrid fractional laser: A multi-center trial on the safety and efficacy for photorejuvenation. Journal of Drugs in Dermatology, 17(11), 1164–1168. https://pubmed.ncbi.nlm.nih.gov/30481954/
Fusano, M., Bencini, P. L., & Galimberti, M. G. (2022). Hybrid fractional laser treatment for photodamaged facial skin rejuvenation 6 years following fractional CO₂: Comparison of clinical outcome and patients' satisfaction. Lasers in Surgery and Medicine, 54(8), 1045–1050. https://doi.org/10.1002/lsm.23583
Brown, M. M., & Ortiz, A. (2019). Hybrid fractional ablative and nonablative laser resurfacing of actinic keratoses. Dermatologic Surgery, 45(3), 468–470. https://doi.org/10.1097/DSS.0000000000001569
Notes on Evidence Quality & Use
All references in this section are peer-reviewed and published in indexed scientific journals. The HALO hybrid fractional laser has the strongest independent clinical evidence base of the non-BBL devices in this library, with peer-reviewed multicentre trials and independent replication. The CO₂ fractional laser literature is well-established with decades of independent research. Manufacturer association: Pozner & DiBernardo (2018) is the primary HALO clinical trial; no commercial conflicts are disclosed in that publication.
PubMed records verified March 2026. DOI links are functional at time of compilation; journal access may require institutional subscription for full text.
All references are cited in APA 7th edition format. Where available, hyperlinked DOIs are provided for direct article access. References are verified against PubMed records (pubmed.ncbi.nlm.nih.gov). All cited articles are peer-reviewed and indexed in PubMed or equivalent scholarly databases. Evidence quality notes are included where relevant to clinical application.
Foundational Science — Microneedling-Facilitated Topical Delivery
Hou, A., Cohen, B., Haimovic, A., & Elbuluk, N. (2017). Microneedling: A comprehensive review. Dermatologic Surgery, 43(3), 321–339. https://doi.org/10.1097/DSS.0000000000000924
Singh, A., & Yadav, S. (2016). Microneedling: Advances and widening horizons. Indian Dermatology Online Journal, 7(4), 244–254. https://doi.org/10.4103/2229-5178.185468
Growth Factor & Stem Cell Conditioned Media — Mechanism
Cho, J. W., Kim, S. A., & Lee, K. S. (2012). Platelet-rich plasma induces increased expression of G1 cell cycle regulators, type I collagen, and matrix metalloproteinase-1 in human skin fibroblasts. International Journal of Molecular Medicine, 29(1), 32–38. https://doi.org/10.3892/ijmm.2011.803
Notes on Evidence Quality & Use
All references in this section are peer-reviewed and published in indexed scientific journals. The Procell Serums Microneedling/Microchanneling Serum Selection Guide (linked above) is a manufacturer document and is not a peer-reviewed publication. The references included represent the best available independent peer-reviewed evidence supporting the biological rationale for post-microneedling/microchanneling serum application. Dedicated peer-reviewed clinical trials specifically evaluating Procell serum formulations in combination with microchanneling are not yet indexed in PubMed at time of compilation (March 2026).
PubMed records verified March 2026. DOI links are functional at time of compilation; journal access may require institutional subscription for full text.
All references are cited in APA 7th edition format. Where available, hyperlinked DOIs are provided for direct article access. References are verified against PubMed records (pubmed.ncbi.nlm.nih.gov). All cited articles are peer-reviewed and indexed in PubMed or equivalent scholarly databases. Evidence quality notes are included where relevant to clinical application.
Foundational Science — NAHYCO Hybrid Cooperative Complex Technology
Cassuto, D., Cigni, C., Bellia, G., & Schiraldi, C. (2023). Restoring adipose tissue homeostasis in response to aging: Initial clinical experience with Profhilo Structura®. Gels, 9(8), 614. https://doi.org/10.3390/gels9080614
Clinical Efficacy — Lateral Cheek Fat Compartment Restoration
Sparavigna, A., Grimolizzi, F., Cigni, C., Lualdi, R., & Bellia, G. (2024). Efficacy and tolerability of Profhilo® Structura intended to restore lateral cheek fat compartment: An observational pilot study. Health Science Reports, 7(1), e1743. https://doi.org/10.1002/hsr2.1743
Expert Consensus & Clinical Application Guidance
Forte, R., Salti, G., & Tateo, A. (2024). Profhilo® Structura, current status and future perspectives: A practical review. Plastic and Aesthetic Nursing, 44(3), 213–219. https://doi.org/10.1097/PSN.0000000000000571
Regulatory & Patient Information
Efficacy and tolerability of Profhilo® Structura intended to restore lateral cheek fat compartment: An observational pilot study. (PubMed Central open-access full text — Sparavigna et al. 2024; peer-reviewed citation above)
Restoring Adipose Tissue Homeostasis in Response to Aging — Initial Clinical Experience with Profhilo® Structura. (ResearchGate figure page — Cassuto et al. 2023; peer-reviewed citation above)
Patient Information Leaflet — Profhilo Structura. (IBSA manufacturer patient information leaflet — not a peer-reviewed publication)
TGA Registration — Profhilo Structura.
(Australian regulatory registration document — confirms TGA approval for use in Australia)
Australian regulatory registration document. Confirms TGA approval of Profhilo Structura for use in Australia. Not a peer-reviewed publication. Included for AHPRA-compliant documentation of device regulatory status.
Notes on Evidence Quality & Use
All peer-reviewed references in this section are published in indexed scientific journals. Profhilo Structura is a relatively new formulation with a growing but currently limited independent evidence base; the majority of published clinical studies involve IBSA-employed or IBSA-affiliated authors. The expert consensus practical review (Forte et al., 2024) represents the most clinically applicable independent guidance currently available. Adequately powered independent RCTs are not yet available at time of compilation (March 2026).
PubMed records verified March 2026. DOI links are functional at time of compilation; journal access may require institutional subscription for full text.
Abokwidir, M., & Feldman, S. R. (2016). Rosacea management. Skin Appendage Disorders, 2(1–2), 26–34. https://doi.org/10.1159/000446215
All references are cited in APA 7th edition format. Where available, hyperlinked DOIs are provided for direct article access. References are verified against PubMed records (pubmed.ncbi.nlm.nih.gov). All cited articles are peer-reviewed and indexed in PubMed or equivalent scholarly databases. Evidence quality notes are included where relevant to clinical application.
Retinoids — Teratogenicity and Pregnancy Contraindication
Napoli, K., & Worobec, S. M. (1995). Mechanisms of teratogenicity of retinoids. Medical Hypotheses, 44(6), 479–482. https://doi.org/10.1016/0306-9877(95)90103-5
Yeh, C. C., Wang, Z., Shyong, E. Q., Lin, E., Lin, M., & Bhutiani, M. (2023). Dermatologic medications in pregnancy: A practical review. Journal of the American Academy of Dermatology, 89(5), 895–904. https://doi.org/10.1016/j.jaad.2023.04.055
Hydroquinone — Pregnancy Avoidance
Bolanca, I., Bolanca, Z., Kuna, K., Vukovic, A., Tuckar, N., Herman, R., & Gruber, F. (2008). Chloasma — the mask of pregnancy. Collegium Antropologicum, 32(Suppl 2), 139–141. https://pubmed.ncbi.nlm.nih.gov/19138024/
SPF/Mineral Sunscreen — Safety in Pregnancy
Schneider, S. L., & Lim, H. W. (2019). Review of environmental effects of oxybenzone and other sunscreen active ingredients. Journal of the American Academy of Dermatology, 80(1), 266–271. https://doi.org/10.1016/j.jaad.2018.06.033
Niacinamide & Vitamin C — Safety Profile
Pullar, J. M., Carr, A. C., & Vissers, M. C. M. (2017). The roles of vitamin C in skin health. Nutrients, 9(8), 866. https://doi.org/10.3390/nu9080866
Additional research
Pregnancy Skincare: Choices (SkinCeuticals & Synergie Skin) — Patient Information (general advice only).
(Avery Aesthetics practice-generated patient handout — not a peer-reviewed publication)
Notes on Evidence Quality & Use
All references in this section are peer-reviewed and published in indexed scientific journals. Pregnancy skincare guidance should always be discussed with the patient's treating obstetrician or GP, as individual circumstances and medication interactions vary. The Avery Aesthetics patient handout (linked above) is a practice-generated guidance document and is not a peer-reviewed publication; the peer-reviewed references in this section provide the evidence basis from which that guidance is derived. None of the peer-reviewed sources in this section have commercial conflicts of interest.
PubMed records verified March 2026. DOI links are functional at time of compilation; journal access may require institutional subscription for full text.
All references are cited in APA 7th edition format. Where available, hyperlinked DOIs are provided for direct article access. References are verified against PubMed records (pubmed.ncbi.nlm.nih.gov). All cited articles are peer-reviewed and indexed in PubMed or equivalent scholarly databases. Evidence quality notes are included where relevant to clinical application.
Murray, J. C., Burch, J. A., Streilein, R. D., Iannacchione, M. A., Hall, R. P., & Pinnell, S. R. (2008). A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation. Journal of the American Academy of Dermatology, 59(3), 418–425. New Clinical Evidence C E Ferulic - Proven Further PDF.